October 04, 2024
CMS has released new guidance outlining the process for the second cycle of negotiations under the Medicare Drug Price Negotiation Program.
The guidance also summarizes how CMS will help ensure Medicare beneficiaries can access drugs at the negotiated prices from the first and second cycles when those prices become effective during 2026 and 2027.
“We are continuing to implement the prescription drug law thoughtfully, prioritizing engagement with all interested parties, and ensuring the process is as transparent and inclusive as possible,” said Dr. Meena Seshamani, MD, PhD, CMS deputy administrator and director of the Center for Medicare.
Here’s what you need to know:
A fact sheet and the final guidance from CMS are available online.
Tags: Access to Care | Affordable Prescription Drugs | Medicare
Click on topic below for category-specific news articles.
Related Links